Siemens Healthineers' advanced imaging technologies, such as its Artis zeego robotic angiography system, guide these types of interventional procedures for precise application of treatment. The protocol known as syngo DynaCT 360, which is specific to the Artis zeego, enables visualization of the full abdomen or thorax -- a feature unique to Siemens Healthineers. The syngo DynaCT 360 protocol helps physicians better visualize large tumors spread throughout the liver, allowing them to more accurately plan the intervention, thereby enhancing procedure safety and confidence. A Saturday, June 4 ASCO Industry Expert Theatre symposium co-hosted by Siemens Healthineers and Sirtex Medical showcases how image guidance plays a key role in the delivery of radioactive microspheres during treatment of liver tumors. Titled "Advanced Imaging for Therapy Management of Selective Internal Radiation Therapy (SIRT) for Non-resectable Primary and Secondary Liver Malignancies," the 60-minute session begins at 9:15 a.m.

Prostate


One in seven men develop prostate cancer at some point during their lifetime.3 In the U.S. alone, one million men undergo a biopsy for the disease each year.4 Conventional diagnosis of prostate cancer typically involves a transrectal biopsy, a painful and invasive procedure. In January, Siemens Healthineers released its noninvasive SEEit prostate magnetic resonance imaging (MR) solution, which enables users of the company's high-performance MAGNETOM Aera 1.5T and MAGNETOM Skyra 3T systems to perform a routine prostate MRI exam in 10 minutes without an endorectal coil. SEEit combines high-density coil technology with unique RESOLVE diffusion technology, which provides physicians with high resolution, low distortion diffusion-weighted imaging (DWI) for accurate depiction of lesions.5

Breast

A recent study involving 22 radiologists demonstrated that all readers improved their accuracy in detecting and diagnosing breast cancers when reading the Siemens 3D digital breast tomosynthesis images in adjunct with full field digital mammography (FFDM/ 2D) versus traditional 2D mammograms. Last year, Siemens Healthineers unveiled its MAMMOMAT Inspiration with Tomosynthesis Option – the breast tomosynthesis add-on option for the company's MAMMOMAT Inspiration digital mammography platform, which in the meantime has been FDA approved for stand-alone use. This breast tomosynthesis algorithm reconstructs multiple 2D images of the breast into a 3D reconstruction to enable detection of tumors hidden by overlapping breast tissue, enabling more accurate diagnosis than standard 2D digital mammography.

US Press Room Homepage